Neuroimaging of Escitalopram in Autism Spectrum Disorder
Clinical trial NCT06826326 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06826326
- Sponsor
- Kathryn Unruh
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-28
- Primary completion
- 2026-12-30
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.